SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Research Triangle Ventures
Research Triangle Ventures, a venture capital firm, specialized in investing in seed and early stage technology companies located in North Carolina.
